OHSU Knight Cancer Institute
@ohsuknight.bsky.social
A leader in cancer research, the OHSU Knight Cancer Institute provides individually-tailored, compassionate care for patients, from diagnosis through survivorship.
Pinned
Phil and Penny Knight announced today a record-breaking $2 billion gift to the Oregon Health & Science University’s Knight Cancer Institute to transform the future of cancer care and set a new standard globally.
Thank you to Phil and Penny Knight for their incredible generosity.
#GiveCancerHell
Thank you to Phil and Penny Knight for their incredible generosity.
#GiveCancerHell
In the 80s, Dr. Brian Druker theorized that kinase inhibitors could be transformative for cancer care.
Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
November 25, 2025 at 5:15 PM
In the 80s, Dr. Brian Druker theorized that kinase inhibitors could be transformative for cancer care.
Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
Dr. Laura Heiser discusses the latest advancements in the understanding of cancer evolution and what to expect at the upcoming "Cancer Evolution: The Dynamics of Progression and Persistence" conference.
Learn more (via @theaacr.bsky.social): https://bit.ly/486G9as
Learn more (via @theaacr.bsky.social): https://bit.ly/486G9as
Evolving Our Understanding of Cancer’s Evolution, Progression, and Persistence
Laura M. Heiser, PhD, and Mara H. Sherman, PhD share insights on cancer evolution as they preview an upcoming AACR Special Conference.
bit.ly
November 24, 2025 at 8:00 PM
Dr. Laura Heiser discusses the latest advancements in the understanding of cancer evolution and what to expect at the upcoming "Cancer Evolution: The Dynamics of Progression and Persistence" conference.
Learn more (via @theaacr.bsky.social): https://bit.ly/486G9as
Learn more (via @theaacr.bsky.social): https://bit.ly/486G9as
ICYMI ⤵️
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
November 21, 2025 at 8:11 PM
ICYMI ⤵️
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
Today, our researchers, clinicians, and staff wore purple in honor of World Pancreatic Cancer Day.
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
November 21, 2025 at 12:50 AM
Today, our researchers, clinicians, and staff wore purple in honor of World Pancreatic Cancer Day.
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
We’re excited to announce that OHSU has received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
November 13, 2025 at 10:17 PM
We’re excited to announce that OHSU has received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
“A drug that targets enolase 1 could help improve the treatment of these cancers, too.”
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
November 13, 2025 at 4:53 PM
“A drug that targets enolase 1 could help improve the treatment of these cancers, too.”
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for survivors.
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
November 10, 2025 at 3:52 PM
Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for survivors.
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
Without samples of early cancer, it’s hard to understand the changes that occur as healthy tissue becomes cancerous.
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
November 9, 2025 at 3:54 PM
Without samples of early cancer, it’s hard to understand the changes that occur as healthy tissue becomes cancerous.
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
A new molecule developed by researchers at @OHSUNews offers a promising avenue to treat intractable cases of triple-negative #BreastCancer, which is a form of cancer that is notoriously aggressive and lacks effective treatments.
#OHSUResearch: https://bit.ly/480D3pv
#OHSUResearch: https://bit.ly/480D3pv
November 7, 2025 at 6:45 PM
A new molecule developed by researchers at @OHSUNews offers a promising avenue to treat intractable cases of triple-negative #BreastCancer, which is a form of cancer that is notoriously aggressive and lacks effective treatments.
#OHSUResearch: https://bit.ly/480D3pv
#OHSUResearch: https://bit.ly/480D3pv
Congratulations to Dr. Lisa Coussens on being honored with the 2025 @metastasisresearch.bsky.social's Women in Science Research award for her exceptional, demonstrable contribution to scientific discovery in the field of metastasis research.
November 6, 2025 at 11:22 PM
Congratulations to Dr. Lisa Coussens on being honored with the 2025 @metastasisresearch.bsky.social's Women in Science Research award for her exceptional, demonstrable contribution to scientific discovery in the field of metastasis research.
Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for childhood cancer survivors.
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
November 4, 2025 at 4:06 PM
Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for childhood cancer survivors.
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
November is Lung Cancer Awareness Month 🤍
Here are 🔟 facts to know about lung cancer.
Here are 🔟 facts to know about lung cancer.
November 3, 2025 at 10:32 PM
November is Lung Cancer Awareness Month 🤍
Here are 🔟 facts to know about lung cancer.
Here are 🔟 facts to know about lung cancer.
“These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predicting cancer initiation.”
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
November 3, 2025 at 8:22 PM
“These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predicting cancer initiation.”
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
“We expected to find some variations in polypectomy technique, but the results were surprising; overall, cold snare usage was lower than expected, given that this is the recommended method for removing most small polyps.”
- Dr. Seth Crockett (via @medscape.com): https://wb.md/4o9v5jz
- Dr. Seth Crockett (via @medscape.com): https://wb.md/4o9v5jz
Polypectomy Best Practices Not Routinely Followed in US
New ‘concerning’ data find that most US endoscopists aren’t following current polypectomy guidelines for polyps < 1 cm, potentially exposing patients to unnecessary risks.
www.medscape.com
November 3, 2025 at 3:51 PM
“We expected to find some variations in polypectomy technique, but the results were surprising; overall, cold snare usage was lower than expected, given that this is the recommended method for removing most small polyps.”
- Dr. Seth Crockett (via @medscape.com): https://wb.md/4o9v5jz
- Dr. Seth Crockett (via @medscape.com): https://wb.md/4o9v5jz
Spooky season success! 🎃👻
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
November 1, 2025 at 8:05 PM
Spooky season success! 🎃👻
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
The Byrne lab's findings suggest that improving CD4+ T cell activation in future immunotherapies will improve outcomes for patients who have historically been resistant to immune-targeting treatments.
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
October 29, 2025 at 4:10 PM
The Byrne lab's findings suggest that improving CD4+ T cell activation in future immunotherapies will improve outcomes for patients who have historically been resistant to immune-targeting treatments.
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
A study led by Dr. Seth Crocket finds that fewer than 60% of procedures use the recommended technique for removing colon polyps smaller than 1 cm.
#OHSUResearch (via @medscape.com): https://wb.md/4o9v5jz
#OHSUResearch (via @medscape.com): https://wb.md/4o9v5jz
Polypectomy Best Practices Not Routinely Followed in US
New ‘concerning’ data find that most US endoscopists aren’t following current polypectomy guidelines for polyps < 1 cm, potentially exposing patients to unnecessary risks.
www.medscape.com
October 28, 2025 at 8:48 PM
A study led by Dr. Seth Crocket finds that fewer than 60% of procedures use the recommended technique for removing colon polyps smaller than 1 cm.
#OHSUResearch (via @medscape.com): https://wb.md/4o9v5jz
#OHSUResearch (via @medscape.com): https://wb.md/4o9v5jz
Reposted by OHSU Knight Cancer Institute
Honored to still be in the fight against cancer. Go get screened!
Today, @portland-gov.bsky.social observed Breast Cancer Awareness Month by bringing together leaders, professionals, nonprofit partners, and youth advocates to emphasize the importance of early detection, equitable access to care, and community support for everyone facing #BreastCancer.
October 22, 2025 at 8:54 PM
Honored to still be in the fight against cancer. Go get screened!
Using the immune system to fight cancer has revolutionized how scientists treat tumors, but this approach is not effective for all patients.
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
October 23, 2025 at 9:36 PM
Using the immune system to fight cancer has revolutionized how scientists treat tumors, but this approach is not effective for all patients.
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
Today, @portland-gov.bsky.social observed Breast Cancer Awareness Month by bringing together leaders, professionals, nonprofit partners, and youth advocates to emphasize the importance of early detection, equitable access to care, and community support for everyone facing #BreastCancer.
October 22, 2025 at 7:47 PM
Today, @portland-gov.bsky.social observed Breast Cancer Awareness Month by bringing together leaders, professionals, nonprofit partners, and youth advocates to emphasize the importance of early detection, equitable access to care, and community support for everyone facing #BreastCancer.
Fall foliage is in full force on Marquam Hill 🍂🍃🍁
October 17, 2025 at 6:06 PM
Fall foliage is in full force on Marquam Hill 🍂🍃🍁
“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.”
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Specialized treatment for complex abdominal cancer saves OHSU patient's life | OHSU Foundation
When Lisa Sayer learned she had appendix cancer that was spreading through her abdomen, she looked to the OHSU Knight Cancer Institute.
ohsufoundation.org
October 17, 2025 at 4:30 PM
“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.”
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Reposted by OHSU Knight Cancer Institute
Many thanks @americancancersoc.bsky.social for today’s policy breakfast @ @ohsuknight.bsky.social. Speakers shared powerful insights on advancing cancer research amid historic funding uncertainty. We must ensure that our groundbreaking PNW research continues to improve lives locally & globally.
October 14, 2025 at 8:33 PM
Many thanks @americancancersoc.bsky.social for today’s policy breakfast @ @ohsuknight.bsky.social. Speakers shared powerful insights on advancing cancer research amid historic funding uncertainty. We must ensure that our groundbreaking PNW research continues to improve lives locally & globally.
“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.”
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Specialized treatment for complex abdominal cancer saves OHSU patient's life | OHSU Foundation
When Lisa Sayer learned she had appendix cancer that was spreading through her abdomen, she looked to the OHSU Knight Cancer Institute.
ohsufoundation.org
October 14, 2025 at 8:26 PM
“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.”
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️
Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received.
Learn more about Lisa's story ⤵️